跳至主要内容
临床试验/NCT01918462
NCT01918462已完成不适用

Protective Immune Mechanisms in Alcoholic Hepatitis

University of Aarhus1 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2013年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
51
试验地点
1
主要终点
Frequency of IL-22-producing cells

研究概览

简要总结

The purpose of this study is to investigate the production, effects and interactions of the hepato-protective cytokine interleukine (IL)-22 in patients with alcoholic hepatitis.

详细描述

The investigators will study hepatic biopsies from patients with alcoholic hepatitis. In these biopsies, the investigators will assess the production of IL-22 and which cells produce the cytokine. The investigators will study the expression of the IL-22 receptor and also the production of the IL-22 binding protein, which can inhibit the actions of the cytokine.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 69 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of alcoholic hepatitis:
  • relevant history of alcohol consumption (>40g/day for a minimum of 6 months with cessation of consumption no earlier than 3 months prior to admission)
  • bilirubin > 80 mol/l
  • neutrophil granulocytes > 10x10^9/L
  • exclusion of other liver pathology including biliary disease
  • histological verification on liver biopsy
  • Written, informed consent

排除标准

  • Other chronic inflammatory or autoimmune diseases
  • Severe, acute bacterial infection (peritonitis, sepsis, pneumonia, urinary tract infection etc.)
  • Prednisolon or pentoxifylline treatment within the past 8 weeks
  • Pregnancy

结局指标

主要结局

Frequency of IL-22-producing cells

时间窗: at day 1 ( the day of diagnosis/arrival to the department)

This will be detected in hepatic biopsies taken at inclusion to the study.

次要结局

  • IL-22 binding protein(at day 1 ( the day of diagnosis/arrival to the department))
  • IL-22 receptor(at day 1 ( the day of diagnosis/arrival to the department))
  • Signalling molecules and markers of hepatocyte destruction(at day 1, at day 7 and at day 90 after diagnosis.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验